• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

MRI helps predict risk of local recurrence in upper rectal cancers

bys25qthea
January 24, 2014
in Chronic Disease, Gastroenterology, Imaging and Intervention, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD/Navy

1. Patients with mesorectal invasion of more than 5mm and sacral-side involvement (seen on MRI) demonstrated higher rates of local recurrence.  

Evidence Rating Level: 2 (Good) 

Study Rundown: Upper rectal cancers (URC), when compared to middle and lower rectal cancers, have a lower risk of local recurrence. This is because URCs are located above the peritoneal reflection, allowing for clear circumferential resection. That being said, the incidence of URC recurrence may be further reduced with the use of preoperative radiotherapy (RT). This study aimed to use MRI to identify URCs that pose the largest threat of recurrence. MRI can detect the proximity of the tumor to the anal verge as well as its distance from the peritoneal reflection. The investigators demonstrated that URCs identified as high risk by MRI were more likely to recur when compared with those identified as intermediate or moderate risk. More specifically, they demonstrated that tumors located on the sacral side with mesorectal invasion greater than 5mm were at an increased risk for local recurrence. These findings suggest that high risk URCs may require additional treatment modalities – perhaps including preoperative radiotherapy. This study paves the way for future investigations on the efficacy of RT in the treatment high risk URC.

Click to read the study in Annals of Surgery

Relevant Reading: Use of surgical procedures and adjuvant therapy in rectal cancer treatment

In-Depth [prospective cohort]: This study used MRI to identify URCs that were at high risk for the study’s primary endpoint, local recurrence. The investigators examined 110 cases of URC and stratified them into 3 groups: intermediate, moderate, and high risk. This stratification was defined using Gunderson’s risk group classification. The anatomical location and mesorectal infiltration was noted for tumors in each of the groups. Though the overall number of cases with local recurrence was low, there was a difference in incidence of recurrence between risk groups. The rates of recurrence in the intermediate, moderate, and high risk groups with sacral-side location were 3%, 4.8%, and 8.7%, respectively. When combined with extensive mesorectal infiltration, the rates were 11.1%, 33.3%, and 18.2%, respectively. Multivariate analyses showed a significant rate of recurrence (p > .05) in tumors with mesorectal infiltration of over 5mm and location on the sacral side. The authors did not compare this sample of patients with another that received preoperative RT – such a study could provide useful information about the management of high risk URCs.

RELATED REPORTS

Neoadjuvant dostarlimab is a promising treatment option in locally advanced dMMR rectal cancer

Adherence to pre-treatment imaging guidelines for staging in rectal cancer is increasing, but a gap still remains

Capecitabine + oxaliplatin chemoradiotherapy does not increase survival, but increases toxicity, compared to capecitabine alone in the postoperative treatment of rectal cancer

By Amir Tarsha and Chaz Carrier

More from this author: Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer, Secondary mastoid obliteration improves quality of life for patients with chronic otitis media, Healthcare reform linked with reduced racial disparities in surgical care, VATS lobectomy may be preferred in COPD with non-small-cell lung cancer, One-on-one training leads to improved virtual reality laparoscopic performance

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: mrirectal cancer
Previous Post

Solanezumab does not improve cognition or functioning in Alzheimer’s disease [EXPEDITION Trials]

Next Post

Childhood cancer not associated with future PTSD

RelatedReports

Patient Basics: Anal Disorders
Oncology

Neoadjuvant dostarlimab is a promising treatment option in locally advanced dMMR rectal cancer

June 13, 2022
Radiofrequency ablation of hepatic metastases in colorectal cancer linked with improved survival
Oncology

Adherence to pre-treatment imaging guidelines for staging in rectal cancer is increasing, but a gap still remains

April 4, 2022
Genetic, environmental risk assessment does not increase colon cancer screening
Chronic Disease

Capecitabine + oxaliplatin chemoradiotherapy does not increase survival, but increases toxicity, compared to capecitabine alone in the postoperative treatment of rectal cancer

December 3, 2021
#VisualAbstract: Prevalence of toxigenic and non-toxigenic asymptomatic Clostridioides difficile colonization in pediatric populations
StudyGraphics

#VisualAbstract: Magnetic resonance imaging-targeted biopsy noninferior to standard biopsy for prostate cancer screening

August 12, 2021
Next Post
Childhood cancer not associated with future PTSD

Childhood cancer not associated with future PTSD

Mitochondrial DNA variant found in normal-tension glaucoma patients

Classics Series, Landmark Trials in Medicine

Childhood febrile seizure characteristics associated with epilepsy diagnosis [Pediatrics Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.